NanoVibronix (NAOV) Competitors $7.16 -0.18 (-2.45%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$7.19 +0.03 (+0.42%) As of 04/17/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAOV vs. NEPH, NXGL, RVP, PTHL, IRIX, QTI, XAIR, LFWD, VVOS, and PETVShould you be buying NanoVibronix stock or one of its competitors? The main competitors of NanoVibronix include Nephros (NEPH), NEXGEL (NXGL), Retractable Technologies (RVP), Pheton Holdings Ltd Class A Ordinary Shares (PTHL), IRIDEX (IRIX), QT Imaging (QTI), Beyond Air (XAIR), ReWalk Robotics (LFWD), Vivos Therapeutics (VVOS), and PetVivo (PETV). These companies are all part of the "medical equipment" industry. NanoVibronix vs. Nephros NEXGEL Retractable Technologies Pheton Holdings Ltd Class A Ordinary Shares IRIDEX QT Imaging Beyond Air ReWalk Robotics Vivos Therapeutics PetVivo Nephros (NASDAQ:NEPH) and NanoVibronix (NASDAQ:NAOV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk. Which has more risk and volatility, NEPH or NAOV? Nephros has a beta of 1.05, suggesting that its stock price is 5% more volatile than the S&P 500. Comparatively, NanoVibronix has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Do analysts rate NEPH or NAOV? Nephros currently has a consensus target price of $5.00, suggesting a potential upside of 155.23%. Given Nephros' stronger consensus rating and higher possible upside, analysts clearly believe Nephros is more favorable than NanoVibronix.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nephros 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NanoVibronix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media refer more to NEPH or NAOV? In the previous week, NanoVibronix had 1 more articles in the media than Nephros. MarketBeat recorded 1 mentions for NanoVibronix and 0 mentions for Nephros. Nephros' average media sentiment score of 0.00 beat NanoVibronix's score of -0.33 indicating that Nephros is being referred to more favorably in the media. Company Overall Sentiment Nephros Neutral NanoVibronix Neutral Which has better earnings and valuation, NEPH or NAOV? Nephros has higher revenue and earnings than NanoVibronix. Nephros is trading at a lower price-to-earnings ratio than NanoVibronix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNephros$14.16M1.47-$1.58M-$0.09-21.77NanoVibronix$2.56M2.12-$3.71M-$13.53-0.53 Does the MarketBeat Community believe in NEPH or NAOV? NanoVibronix received 58 more outperform votes than Nephros when rated by MarketBeat users. Likewise, 57.26% of users gave NanoVibronix an outperform vote while only 43.33% of users gave Nephros an outperform vote. CompanyUnderperformOutperformNephrosOutperform Votes1343.33% Underperform Votes1756.67% NanoVibronixOutperform Votes7157.26% Underperform Votes5342.74% Is NEPH or NAOV more profitable? Nephros has a net margin of -6.86% compared to NanoVibronix's net margin of -93.80%. Nephros' return on equity of -11.39% beat NanoVibronix's return on equity.Company Net Margins Return on Equity Return on Assets Nephros-6.86% -11.39% -8.30% NanoVibronix -93.80%-101.17%-53.03% Do insiders and institutionals have more ownership in NEPH or NAOV? 41.1% of Nephros shares are owned by institutional investors. Comparatively, 16.4% of NanoVibronix shares are owned by institutional investors. 4.1% of Nephros shares are owned by insiders. Comparatively, 7.0% of NanoVibronix shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. SummaryNephros beats NanoVibronix on 11 of the 18 factors compared between the two stocks. Get NanoVibronix News Delivered to You Automatically Sign up to receive the latest news and ratings for NAOV and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NAOV vs. The Competition Export to ExcelMetricNanoVibronixSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.43M$8.59B$5.30B$7.34BDividend YieldN/A1.71%5.12%4.30%P/E Ratio-5.8218.6621.8617.80Price / Sales2.1270.67380.5497.75Price / CashN/A19.6738.2634.64Price / Book3.674.846.453.98Net Income-$3.71M$284.66M$3.22B$247.81M7 Day Performance5.76%1.68%2.85%1.80%1 Month Performance133.22%-5.79%-8.67%-6.81%1 Year Performance-13.21%-21.24%11.46%1.31% NanoVibronix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NAOVNanoVibronix0.1404 of 5 stars$7.16-2.5%N/A-16.0%$5.43M$2.56M-5.8220Short Interest ↑Gap UpNEPHNephros1.7297 of 5 stars$2.02+6.1%$5.00+148.1%-1.6%$21.36M$14.16M-22.3930Positive NewsGap UpNXGLNEXGEL0.4319 of 5 stars$2.75+8.3%N/A+26.3%$21.05M$8.69M-4.7410Short Interest ↑RVPRetractable TechnologiesN/A$0.70+3.1%N/A-31.9%$20.99M$33.05M-1.30240PTHLPheton Holdings Ltd Class A Ordinary SharesN/A$2.76-5.8%N/AN/A$18.17M$448,196.000.0011Positive NewsIRIXIRIDEX1.3541 of 5 stars$0.99+5.0%$2.00+102.0%-67.9%$16.62M$48.67M-1.48120Analyst ForecastQTIQT ImagingN/A$0.60-0.1%N/A-12.1%$16.28M$4.00M0.00N/AGap UpXAIRBeyond Air4.2169 of 5 stars$0.23-0.9%$3.67+1,467.0%-81.3%$16.10M$3.02M-0.2270LFWDReWalk Robotics2.6542 of 5 stars$1.44+0.7%$9.00+525.0%-71.6%$15.31M$25.66M-0.5860Short Interest ↓VVOSVivos Therapeutics1.5898 of 5 stars$2.25-3.4%$6.30+180.0%-21.1%$13.25M$15.03M-0.40160Analyst ForecastNews CoveragePETVPetVivoN/A$0.55+9.9%N/A-22.8%$13.07M$1.05M-1.2220High Trading Volume Related Companies and Tools Related Companies Nephros Competitors NEXGEL Competitors Retractable Technologies Competitors Pheton Holdings Ltd Class A Ordinary Shares Competitors IRIDEX Competitors QT Imaging Competitors Beyond Air Competitors ReWalk Robotics Competitors Vivos Therapeutics Competitors PetVivo Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NAOV) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NanoVibronix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NanoVibronix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NAOV Stock Free NAOV Stock Alerts